Back to top

H.C. Wainwright Keeps Their Buy Rating on CervoMed (CRVO)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on CervoMed today and set a price target of $25.00. Selvaraju covers the Healthcare s...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CervoMed Inc. (CRVO)